542 related articles for article (PubMed ID: 17914088)
1. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P
Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
[TBL] [Abstract][Full Text] [Related]
3. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
4. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast.
Mann RM
Magn Reson Imaging Clin N Am; 2010 May; 18(2):259-76, ix. PubMed ID: 20494311
[TBL] [Abstract][Full Text] [Related]
6. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.
Molland JG; Donnellan M; Janu NC; Carmalt HL; Kennedy CW; Gillett DJ
Breast; 2004 Oct; 13(5):389-96. PubMed ID: 15454194
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
[TBL] [Abstract][Full Text] [Related]
11. Is pleomorphic lobular carcinoma really a distinct clinical entity?
Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
[TBL] [Abstract][Full Text] [Related]
12. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
[TBL] [Abstract][Full Text] [Related]
13. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
14. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
15. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best?
McGhan LJ; Wasif N; Gray RJ; Giurescu ME; Pizzitola VJ; Lorans R; Ocal IT; Stucky CC; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():255-62. PubMed ID: 20853043
[TBL] [Abstract][Full Text] [Related]
16. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients.
Cutuli B; Cottu PH; Guastalla JP; Mechin H; Costa A; Jourdan R
Breast Cancer Res Treat; 2006 Jan; 95(1):55-64. PubMed ID: 16261401
[TBL] [Abstract][Full Text] [Related]
17. Selecting patients for breast-conserving therapy: the importance of lobular histology.
Morrow M; Keeney K; Scholtens D; Wei J; Steel J; Khan SA
Cancer; 2006 Jun; 106(12):2563-8. PubMed ID: 16683225
[TBL] [Abstract][Full Text] [Related]
18. Impact of the diagnostic methods on the therapeutic strategies.
Greco M; Agresti R; Giovanazzi R
Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
20. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
